02/26/2025
6:27 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:29 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:31 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:33 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:36 PM | Lang Matthew (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Lyell Immunopharma (Subject)
| Form SCHEDULE 13G/A | |
01/24/2025
3:39 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:10 AM | Lyell Immunopharma (Filer)
| Form 8-K/A | |
12/09/2024
8:03 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
7:39 AM | Lyell Immunopharma (Filer)
| Form 424B5 | |
12/05/2024
11:15 PM | Lyell Immunopharma (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for LYEL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lyell Immunopharma and its competitors with MarketBeat's FREE daily newsletter. |
11/29/2024
3:19 PM | Lyell Immunopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/26/2024
3:05 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:30 PM | Lyell Immunopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:54 PM | Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2024
3:56 PM | Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
5:00 PM | Foresite Capital Fund IV, L.P. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G | |
10/31/2024
3:45 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:06 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
7:32 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
3:41 PM | Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:03 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
7:06 AM | Lyell Immunopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
7:12 AM | Lyell Immunopharma (Filer)
| Form 424B5 | |
05/05/2024
11:15 PM | Lyell Immunopharma (Filer)
| Form EFFECT | |
04/22/2024
3:15 PM | Lyell Immunopharma (Filer)
| Form DEF 14A | |
04/22/2024
3:16 PM | Lyell Immunopharma (Filer)
| Form DEFA14A | |
04/22/2024
3:17 PM | Lyell Immunopharma (Filer)
| Form ARS | |
Free LYEL Stock Alerts